Related Experiment Video
Updated: Jun 17, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years
Paul A Northcott1, James T Rutka, Michael D Taylor
1Division of Neurosurgery, Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, University of Toronto, Ontario, Canada.
Abstract:
Advances in the field of genomics have recently enabled the unprecedented characterization of the cancer genome, providing novel insight into the molecular mechanisms underlying malignancies in humans. The application of high-resolution microarray platforms to the study of medulloblastoma has revealed new oncogenes and tumor suppressors and has implicated changes in DNA copy number, gene expression, and methylation state in its etiology. Additionally, the integration of medulloblastoma genomics with patient clinical data has confirmed molecular markers of prognostic significance and highlighted the potential utility of molecular disease stratification. The advent of next-generation sequencing technologies promises to greatly transform our understanding of medulloblastoma pathogenesis in the next few years, permitting comprehensive analyses of all aspects of the genome and increasing the likelihood that genomic medicine will become part of the routine diagnosis and treatment of medulloblastoma.
Insights
Genomic studies of medulloblastoma reveal key cancer genes and DNA alterations. Integrating this genomic data with clinical information aids in patient stratification and treatment strategies.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Cancer genome characterization provides insights into human malignancies.
- Medulloblastoma research utilizes high-resolution microarray platforms.
Observation:
- Microarray analysis identified novel oncogenes and tumor suppressors in medulloblastoma.
- Changes in DNA copy number, gene expression, and methylation are implicated in medulloblastoma etiology.
- Integration of genomic data with clinical information confirmed prognostic markers.
Findings:
- Genomic alterations are crucial in medulloblastoma development.
- Molecular markers hold prognostic significance for medulloblastoma patients.
- Molecular stratification shows potential for disease management.
Implications:
- Next-generation sequencing will revolutionize medulloblastoma pathogenesis understanding.
- Comprehensive genomic analysis will enhance diagnosis and treatment.
- Genomic medicine is poised to become standard in medulloblastoma care.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Genomics
Karyotyping
Evolutionary Relationships through Genome Comparisons
Modern Molecular Taxonomy